Metformin Regulates TET2 Expression to Inhibit Endometrial Carcinoma Proliferation: A New Mechanism

OBJECTIVES: To investigate the relationship between TET2 expression and endometrial cancer’s clinicopathological features and prognosis, and the effect of metformin on TET2 and 5hmC levels in endometrial cancer cells. METHODS: The clinical significance of TET2 expression in endometrial carcinoma was...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jingbo, Kuang, Lei, Li, Yanyu, Wang, Qing, Xu, Hui, Liu, Jianwei, Zhou, Xueyan, Li, Yang, Zhang, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035737/
https://www.ncbi.nlm.nih.gov/pubmed/35480097
http://dx.doi.org/10.3389/fonc.2022.856707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035737/
https://www.ncbi.nlm.nih.gov/pubmed/35480097
http://dx.doi.org/10.3389/fonc.2022.856707

Ejemplares similares